WallStreetZenWallStreetZen

NASDAQ: OPK
Opko Health Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Opko Health revenue was $713.14M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $183.6M, up 5.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OPK annual revenue was $713.1M, with -17.4% growth year-over-year.

OPK past revenue growth

How has OPK's revenue growth performed historically?

Company
-17.41%
Industry
3.57%
Market
20.21%
OPK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OPK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OPK's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OPK revenue history

Current Revenue
$713.1M
Current Earnings
-$53.2M
Current Profit Margin
-7.5%

Be the first to know when OPK announces revenue.

OPK Revenue History By Year

OPK Yearly RevenueOPK RevenueOPK ChangeOPK Revenue Growth
2024-12-31$713.14M-$150.35M-17.41%
2023-12-31$863.50M-$140.70M-14.01%
2022-12-31$1.00B-$770.52M-43.42%
2021-12-31$1.77B$339.31M+23.64%
2020-12-31$1.44B$533.48M+59.15%
2019-12-31$901.94M-$88.33M-8.92%
2018-12-31$990.27M$24.26M+2.51%
2017-12-31$966.01M-$151.49M-13.56%
2016-12-31$1.12B$625.76M+127.25%
2015-12-31$491.74M$400.61M+439.63%
2014-12-31$91.13M-$5.41M-5.60%
2013-12-31$96.53M$49.49M+105.19%
2012-12-31$47.04M$19.07M+68.14%
2011-12-31$27.98M-$515.00k-1.81%
2010-12-31$28.49M$24.08M+544.95%
2009-12-31$4.42M-$5.02M-53.20%
2008-12-31$9.44M$8.59M+1,014.52%
2007-12-31$847.00kN/AN/A
2006-12-31$0.00N/AN/A
2005-12-31$0.00N/AN/A
2004-12-31$0.00N/AN/A
2003-12-31$0.00N/AN/A
2002-12-31$0.00N/AN/A
2001-12-31$0.00N/AN/A
2000-12-31$0.00N/AN/A
1999-12-31$0.00N/AN/A
1998-12-31$0.00N/AN/A
1997-12-31$0.00N/AN/A
1996-12-31$0.00N/AN/A
1995-12-31$0.00N/AN/A

1 of 2

Opko Health Revenue FAQ

What was OPK's revenue last quarter?

On Invalid Date, Opko Health (NASDAQ: OPK) reported Q4 2024 revenue of $183.64 million up 0.95% year over year. In the same quarter last year, Opko Health's revenue was $181.90 million.

What was Opko Health's revenue in 2024?

Opko Health's annual revenue for the twelve months ending Dec 31, 2024 was $713.14 million, a 17.41% decrease year over year.

How much does Opko Health make in a day?

Based on Opko Health annual revenue for the past five years, OPK makes an average of $3,173,130.96 per day.

What was Opko Health's annual revenue growth in the past year?

As of Q1 2025, Opko Health's revenue has grown -17.41% year over year. This is 20.98 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 3.57%. Opko Health's revenue in the past year totaled $713.14 million.

How much does Opko Health make in a year?

Opko Health's revenue by year for the past five years is:
  • Opko Health's revenue for the twelve months ending Dec 31, 2024 was $713.14 million, a 17.41% decrease year over year.
  • Opko Health's annual revenue for Dec 31, 2023 was $863.50 million, a 14.01% decrease from 2022.
  • Opko Health's annual revenue for 2022 was $1.00 billion, a 43.42% decrease from 2021.
  • Opko Health's annual revenue for 2021 was $1.77 billion, a 23.64% increase from 2020.
  • Opko Health's annual revenue for 2020 was $1.44 billion, a 59.15% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.